🔗 Visit the ClinicalTrials.gov page for NCT00313781
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Drug resistance in metastatic castration-resistant prostate cancer. | Nat Rev Clin Oncol | 2010 | 1.86 |
| 2 | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. | World J Gastroenterol | 2008 | 1.31 |
| 3 | Novel targeted therapeutics for metastatic castration-resistant prostate cancer. | Cancer Lett | 2009 | 1.04 |
| 4 | Overcoming drug resistance and treating advanced prostate cancer. | Curr Drug Targets | 2012 | 0.95 |
| 5 | Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2011 | 0.93 |
| 6 | Emerging molecularly targeted therapies in castration refractory prostate cancer. | Prostate Cancer | 2013 | 0.83 |
| 7 | Research in castration-resistant prostate cancer: what does the future hold? | Curr Oncol | 2010 | 0.79 |
| 8 | Future directions in castrate-resistant prostate cancer therapy. | Clin Genitourin Cancer | 2010 | 0.79 |